本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viking Therapeutics, Inc.

32.01
-0.0600-0.19%
盤後32.200.1900+0.59%19:59 EDT
成交量:339.45萬
成交額:1.09億
市值:35.95億
市盈率:-27.76
高:33.16
開:32.16
低:31.28
收:32.07
資料載入中...
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report
2023/07/27

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/01

關聯方擬減持公告

144 - Report of proposed sale of securities